We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DHI Group Inc | NYSE:DHX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.21 | 8.97% | 2.55 | 2.62 | 2.33 | 2.38 | 265,140 | 23:16:34 |
|
|
|
|
|
R
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
£
|
TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
20-3179218
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
1040 Avenue of the Americas, 8
th
Floor
|
|
|
New York, New York
|
|
10018
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
|
|
September 30,
2016 |
|
December 31, 2015
|
||||
ASSETS
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash
|
$
|
29,421
|
|
|
$
|
34,050
|
|
Accounts receivable, net of allowance for doubtful accounts of $2,666 and $2,887
|
37,863
|
|
|
46,380
|
|
||
Income taxes receivable
|
1,654
|
|
|
916
|
|
||
Prepaid and other current assets
|
3,810
|
|
|
3,072
|
|
||
Assets held for sale
|
—
|
|
|
4,265
|
|
||
Total current assets
|
72,748
|
|
|
88,683
|
|
||
Fixed assets, net
|
15,663
|
|
|
15,255
|
|
||
Acquired intangible assets, net
|
49,812
|
|
|
65,292
|
|
||
Goodwill
|
174,640
|
|
|
198,598
|
|
||
Deferred income taxes
|
276
|
|
|
322
|
|
||
Other assets
|
646
|
|
|
785
|
|
||
Total assets
|
$
|
313,785
|
|
|
$
|
368,935
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities
|
|
|
|
||||
Accounts payable and accrued expenses
|
$
|
19,979
|
|
|
$
|
23,883
|
|
Deferred revenue
|
82,384
|
|
|
83,316
|
|
||
Income taxes payable
|
2,762
|
|
|
4,006
|
|
||
Liabilities held for sale
|
—
|
|
|
2,334
|
|
||
Total current liabilities
|
105,125
|
|
|
113,539
|
|
||
Long-term debt, net
|
90,679
|
|
|
99,436
|
|
||
Deferred income taxes
|
9,096
|
|
|
10,849
|
|
||
Accrual for unrecognized tax benefits
|
3,602
|
|
|
3,436
|
|
||
Other long-term liabilities
|
2,947
|
|
|
3,062
|
|
||
Total liabilities
|
211,449
|
|
|
230,322
|
|
||
Commitments and contingencies (Note 7)
|
|
|
|
||||
Stockholders’ equity
|
|
|
|
||||
Convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding
|
—
|
|
|
—
|
|
||
Common stock, $.01 par value, authorized 240,000; issued 81,951 and 80,717 shares, respectively; outstanding: 50,144 and 52,622 shares, respectively
|
820
|
|
|
807
|
|
||
Additional paid-in capital
|
363,744
|
|
|
352,208
|
|
||
Accumulated other comprehensive loss
|
(29,325
|
)
|
|
(20,468
|
)
|
||
Accumulated earnings
|
38,600
|
|
|
49,476
|
|
||
Treasury stock, 31,807 and 28,095 shares, respectively
|
(271,503
|
)
|
|
(243,410
|
)
|
||
Total stockholders’ equity
|
102,336
|
|
|
138,613
|
|
||
Total liabilities and stockholders’ equity
|
$
|
313,785
|
|
|
$
|
368,935
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Revenues
|
$
|
56,073
|
|
|
$
|
65,138
|
|
|
$
|
172,032
|
|
|
$
|
194,710
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Cost of revenues
|
7,943
|
|
|
9,765
|
|
|
24,557
|
|
|
29,255
|
|
||||
Product development
|
6,018
|
|
|
7,938
|
|
|
19,323
|
|
|
22,082
|
|
||||
Sales and marketing
|
19,425
|
|
|
19,779
|
|
|
58,573
|
|
|
60,984
|
|
||||
General and administrative
|
10,101
|
|
|
10,958
|
|
|
32,822
|
|
|
34,059
|
|
||||
Depreciation
|
2,478
|
|
|
2,364
|
|
|
7,639
|
|
|
6,821
|
|
||||
Amortization of intangible assets
|
1,570
|
|
|
3,376
|
|
|
6,106
|
|
|
10,875
|
|
||||
Impairment of goodwill
|
15,369
|
|
|
—
|
|
|
15,369
|
|
|
—
|
|
||||
Impairment of intangible assets
|
9,252
|
|
|
—
|
|
|
9,252
|
|
|
—
|
|
||||
Disposition related and other costs (Note 10)
|
—
|
|
|
—
|
|
|
3,347
|
|
|
—
|
|
||||
Total operating expenses
|
72,156
|
|
|
54,180
|
|
|
176,988
|
|
|
164,076
|
|
||||
Operating income (loss)
|
(16,083
|
)
|
|
10,958
|
|
|
(4,956
|
)
|
|
30,634
|
|
||||
Interest expense
|
(901
|
)
|
|
(831
|
)
|
|
(2,593
|
)
|
|
(2,472
|
)
|
||||
Other income (expense)
|
(1
|
)
|
|
7
|
|
|
(33
|
)
|
|
(2
|
)
|
||||
Income (loss) before income taxes
|
(16,985
|
)
|
|
10,134
|
|
|
(7,582
|
)
|
|
28,160
|
|
||||
Income tax (benefit) expense
|
(144
|
)
|
|
3,623
|
|
|
3,294
|
|
|
10,879
|
|
||||
Net income (loss)
|
$
|
(16,841
|
)
|
|
$
|
6,511
|
|
|
$
|
(10,876
|
)
|
|
$
|
17,281
|
|
|
|
|
|
|
|
|
|
||||||||
Basic earnings (loss) per share
|
$
|
(0.35
|
)
|
|
$
|
0.13
|
|
|
$
|
(0.22
|
)
|
|
$
|
0.33
|
|
Diluted earnings (loss) per share
|
$
|
(0.35
|
)
|
|
$
|
0.12
|
|
|
$
|
(0.22
|
)
|
|
$
|
0.33
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average basic shares outstanding
|
47,719
|
|
|
51,228
|
|
|
48,596
|
|
|
51,792
|
|
||||
Weighted-average diluted shares outstanding
|
47,719
|
|
|
52,230
|
|
|
48,596
|
|
|
53,056
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net income (loss)
|
$
|
(16,841
|
)
|
|
$
|
6,511
|
|
|
$
|
(10,876
|
)
|
|
$
|
17,281
|
|
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment
|
(2,221
|
)
|
|
(3,972
|
)
|
|
(8,857
|
)
|
|
(4,170
|
)
|
||||
Unrealized losses on investments
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
||||
Total other comprehensive loss
|
(2,221
|
)
|
|
(3,975
|
)
|
|
(8,857
|
)
|
|
(4,173
|
)
|
||||
Comprehensive income (loss)
|
$
|
(19,062
|
)
|
|
$
|
2,536
|
|
|
$
|
(19,733
|
)
|
|
$
|
13,108
|
|
|
Nine Months Ended September 30,
|
||||||
|
2016
|
|
2015
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income (loss)
|
$
|
(10,876
|
)
|
|
$
|
17,281
|
|
Adjustments to reconcile net income to net cash flows from operating activities:
|
|
|
|
||||
Depreciation
|
7,639
|
|
|
6,821
|
|
||
Amortization of intangible assets
|
6,106
|
|
|
10,875
|
|
||
Deferred income taxes
|
(1,977
|
)
|
|
(373
|
)
|
||
Amortization of deferred financing costs
|
243
|
|
|
313
|
|
||
Stock based compensation
|
8,750
|
|
|
7,490
|
|
||
Impairment of goodwill
|
15,369
|
|
|
—
|
|
||
Impairment of intangible assets
|
9,252
|
|
|
—
|
|
||
Change in accrual for unrecognized tax benefits
|
166
|
|
|
172
|
|
||
Loss on sale of business
|
639
|
|
|
—
|
|
||
Changes in operating assets and liabilities, net of the effects of acquisitions:
|
|
|
|
||||
Accounts receivable
|
8,047
|
|
|
3,437
|
|
||
Prepaid expenses and other assets
|
(618
|
)
|
|
1,601
|
|
||
Accounts payable and accrued expenses
|
(3,430
|
)
|
|
(2,332
|
)
|
||
Income taxes receivable/payable
|
(2,082
|
)
|
|
6,050
|
|
||
Deferred revenue
|
(493
|
)
|
|
(2,132
|
)
|
||
Other, net
|
(123
|
)
|
|
166
|
|
||
Net cash flows from operating activities
|
36,612
|
|
|
49,369
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Cash received from sale of business
|
2,429
|
|
|
—
|
|
||
Purchases of fixed assets
|
(8,461
|
)
|
|
(6,710
|
)
|
||
Net cash flows from investing activities
|
(6,032
|
)
|
|
(6,710
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Payments on long-term debt
|
(26,000
|
)
|
|
(28,875
|
)
|
||
Proceeds from long-term debt
|
17,000
|
|
|
20,000
|
|
||
Payments under stock repurchase plan
|
(26,179
|
)
|
|
(29,561
|
)
|
||
Payment of acquisition related contingencies
|
—
|
|
|
(3,829
|
)
|
||
Proceeds from stock option exercises
|
2,664
|
|
|
5,897
|
|
||
Purchase of treasury stock related to vested restricted stock and performance stock units
|
(2,779
|
)
|
|
(1,665
|
)
|
||
Excess tax benefit over book expense from stock based compensation
|
400
|
|
|
2,114
|
|
||
Net cash flows from financing activities
|
(34,894
|
)
|
|
(35,919
|
)
|
||
Effect of exchange rate changes
|
(315
|
)
|
|
394
|
|
||
Net change in cash for the period
|
(4,629
|
)
|
|
7,134
|
|
||
Cash, beginning of period
|
34,050
|
|
|
26,777
|
|
||
Cash, end of period
|
$
|
29,421
|
|
|
$
|
33,911
|
|
•
|
Level 1 – Quoted prices for identical instruments in active markets.
|
•
|
Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.
|
•
|
Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
As of September 30, 2016
|
||||||||||||||||||||
|
Total Cost
|
|
Accumulated
Amortization
|
|
Foreign
Currency
Translation
Adjustment
|
|
Impairment
|
|
Acquired
Intangible
Assets, Net
|
|
Weighted-
Average
Amortization
Period
|
||||||||||
Technology
|
$
|
10,308
|
|
|
$
|
(9,408
|
)
|
|
$
|
(834
|
)
|
|
$
|
—
|
|
|
$
|
66
|
|
|
3.8 years
|
Trademarks and brand names—Dice
|
39,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
39,000
|
|
|
Indefinite
|
|||||
Trademarks and brand names—Other
|
23,194
|
|
|
(13,633
|
)
|
|
(2,818
|
)
|
|
(3,168
|
)
|
|
3,575
|
|
|
6.1 years
|
|||||
Customer lists
|
28,473
|
|
|
(12,338
|
)
|
|
(2,880
|
)
|
|
(6,084
|
)
|
|
7,171
|
|
|
7.0 years
|
|||||
Candidate and content database
|
15,918
|
|
|
(14,491
|
)
|
|
(1,427
|
)
|
|
—
|
|
|
—
|
|
|
2.6 years
|
|||||
Acquired intangible assets, net
|
$
|
116,893
|
|
|
$
|
(49,870
|
)
|
|
$
|
(7,959
|
)
|
|
$
|
(9,252
|
)
|
|
$
|
49,812
|
|
|
|
|
As of December 31, 2015
|
||||||||||||||||
|
Total Cost
|
|
Accumulated
Amortization
|
|
Foreign
Currency
Translation
Adjustment
|
|
Acquired
Intangible
Assets, Net
|
|
Weighted-
Average
Amortization
Period
|
||||||||
Technology
|
$
|
10,308
|
|
|
$
|
(8,831
|
)
|
|
$
|
(615
|
)
|
|
$
|
862
|
|
|
3.8 years
|
Trademarks and brand names—Dice
|
39,000
|
|
|
—
|
|
|
—
|
|
|
39,000
|
|
|
Indefinite
|
||||
Trademarks and brand names—Other
|
23,419
|
|
|
(13,156
|
)
|
|
(2,238
|
)
|
|
8,025
|
|
|
6.1 years
|
||||
Customer lists
|
63,373
|
|
|
(42,808
|
)
|
|
(5,068
|
)
|
|
15,497
|
|
|
5.5 years
|
||||
Candidate and content database
|
24,888
|
|
|
(22,088
|
)
|
|
(892
|
)
|
|
1,908
|
|
|
2.4 years
|
||||
Acquired intangible assets, net
|
$
|
160,988
|
|
|
$
|
(86,883
|
)
|
|
$
|
(8,813
|
)
|
|
$
|
65,292
|
|
|
|
October 1, 2016 through December 31, 2016
|
$
|
652
|
|
2017
|
2,228
|
|
|
2018
|
1,781
|
|
|
2019
|
1,476
|
|
|
2020
|
1,421
|
|
|
2021 and thereafter
|
3,254
|
|
|
Total
|
$
|
10,812
|
|
|
September 30,
2016 |
|
December 31,
2015 |
||||
Amounts borrowed:
|
|
|
|
||||
Revolving credit facility
|
$
|
92,000
|
|
|
$
|
101,000
|
|
Less: deferred financing costs, net of accumulated amortization of $1,406 and $1,163
|
(1,321
|
)
|
|
(1,564
|
)
|
||
Total borrowed
|
$
|
90,679
|
|
|
$
|
99,436
|
|
|
|
|
|
||||
Available to be borrowed under revolving facility
|
$
|
158,000
|
|
|
$
|
149,000
|
|
|
|
|
|
||||
Interest rates:
|
|
|
|
||||
LIBOR rate loans:
|
|
|
|
||||
Interest margin
|
2.00
|
%
|
|
2.00
|
%
|
||
Actual interest rates
|
2.56
|
%
|
|
2.25
|
%
|
October 1, 2016 through December 31, 2016
|
$
|
1,169
|
|
2017
|
4,352
|
|
|
2018
|
4,143
|
|
|
2019
|
3,707
|
|
|
2020
|
3,293
|
|
|
2021 and thereafter
|
7,231
|
|
|
Total minimum payments
|
$
|
23,895
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Approximate Dollar Value of Shares Purchased
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
|
|||||||
410,000
|
|
|
$
|
6.70
|
|
|
$
|
2,746,000
|
|
|
$
|
22,313,000
|
|
|
September 30,
2016 |
|
December 31,
2015 |
||||
|
|
|
|
||||
Foreign currency translation adjustment
|
$
|
(29,325
|
)
|
|
$
|
(20,468
|
)
|
|
Foreign currency translation adjustment
|
||
Beginning balance
|
$
|
(27,104
|
)
|
Other comprehensive loss
|
(2,221
|
)
|
|
Ending balance
|
$
|
(29,325
|
)
|
|
Foreign currency translation adjustment
|
|
Unrealized gains on investments
|
|
Total
|
||||||
Beginning balance
|
$
|
(14,107
|
)
|
|
$
|
3
|
|
|
$
|
(14,104
|
)
|
Other comprehensive loss
|
(3,972
|
)
|
|
(3
|
)
|
|
(3,975
|
)
|
|||
Ending balance
|
$
|
(18,079
|
)
|
|
$
|
—
|
|
|
$
|
(18,079
|
)
|
|
Foreign currency translation adjustment
|
||
Beginning balance
|
$
|
(20,468
|
)
|
Other comprehensive loss
|
(8,857
|
)
|
|
Ending balance
|
$
|
(29,325
|
)
|
|
Foreign currency translation adjustment
|
|
Unrealized gains on investments
|
|
Total
|
||||||
Beginning balance
|
$
|
(13,909
|
)
|
|
$
|
3
|
|
|
$
|
(13,906
|
)
|
Other comprehensive loss
|
(4,170
|
)
|
|
(3
|
)
|
|
(4,173
|
)
|
|||
Ending balance
|
$
|
(18,079
|
)
|
|
$
|
—
|
|
|
$
|
(18,079
|
)
|
|
Accrual at
|
|
|
|
|
|
|
|
Accrual at
|
||||||||||
|
December 31, 2015
|
|
Expense
|
|
Cash Payments
|
|
Non-Cash
|
|
September 30, 2016
|
||||||||||
Severance
—
Slashdot Media
|
$
|
—
|
|
|
$
|
981
|
|
|
$
|
(981
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Accelerated stock based compensation expense
—
Slashdot Media
|
—
|
|
|
900
|
|
|
—
|
|
|
(900
|
)
|
|
—
|
|
|||||
Loss on sale of Slashdot Media
|
—
|
|
|
639
|
|
|
—
|
|
|
(639
|
)
|
|
—
|
|
|||||
Severance related to other brands
|
—
|
|
|
827
|
|
|
(827
|
)
|
|
—
|
|
|
—
|
|
|||||
Total
|
$
|
—
|
|
|
$
|
3,347
|
|
|
$
|
(1,808
|
)
|
|
$
|
(1,539
|
)
|
|
$
|
—
|
|
|
|
Three Months Ended September 30, 2016
|
|
Three Months Ended September 30, 2015
|
||||||||||
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
|
2,236,250
|
|
|
$
|
8.10
|
|
|
2,249,600
|
|
|
$
|
8.55
|
|
Granted
|
|
165,700
|
|
|
$
|
6.90
|
|
|
23,500
|
|
|
$
|
8.94
|
|
Forfeited
|
|
(142,875
|
)
|
|
$
|
8.00
|
|
|
(86,875
|
)
|
|
$
|
8.35
|
|
Vested
|
|
(65,250
|
)
|
|
$
|
8.76
|
|
|
(46,125
|
)
|
|
$
|
8.83
|
|
Non-vested at end of period
|
|
2,193,825
|
|
|
$
|
8.00
|
|
|
2,140,100
|
|
|
$
|
8.56
|
|
|
|
Nine Months Ended September 30, 2016
|
|
Nine Months Ended September 30, 2015
|
||||||||||
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
|
2,122,225
|
|
|
$
|
8.54
|
|
|
1,786,581
|
|
|
$
|
8.45
|
|
Granted
|
|
1,199,200
|
|
|
$
|
7.47
|
|
|
1,211,600
|
|
|
$
|
8.85
|
|
Forfeited
|
|
(294,375
|
)
|
|
$
|
8.15
|
|
|
(231,937
|
)
|
|
$
|
8.29
|
|
Vested
|
|
(833,225
|
)
|
|
$
|
8.57
|
|
|
(626,144
|
)
|
|
$
|
8.92
|
|
Non-vested at end of period
|
|
2,193,825
|
|
|
$
|
8.00
|
|
|
2,140,100
|
|
|
$
|
8.56
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2016
|
|
2015
|
||||
Weighted average fair value of PSUs granted
|
|
$
|
7.24
|
|
|
$
|
9.25
|
|
Dividend yield
|
|
—
|
%
|
|
—
|
%
|
||
Risk free interest rate
|
|
0.9
|
%
|
|
1.1
|
%
|
||
Expected volatility
|
|
33.5
|
%
|
|
33.6
|
%
|
|
|
Three Months Ended September 30, 2016
|
|
Three Months Ended September 30, 2015
|
||||||||||
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
|
670,838
|
|
|
$
|
8.03
|
|
|
415,000
|
|
|
$
|
9.25
|
|
Forfeited
|
|
(72,084
|
)
|
|
$
|
8.05
|
|
|
—
|
|
|
$
|
—
|
|
Vested
|
|
(18,750
|
)
|
|
$
|
8.25
|
|
|
—
|
|
|
$
|
—
|
|
Non-vested at end of period
|
|
580,004
|
|
|
$
|
8.02
|
|
|
415,000
|
|
|
$
|
9.25
|
|
|
|
Nine Months Ended September 30, 2016
|
|
Nine Months Ended September 30, 2015
|
||||||||||
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
|
415,000
|
|
|
$
|
9.25
|
|
|
—
|
|
|
$
|
—
|
|
Granted
|
|
417,500
|
|
|
$
|
7.24
|
|
|
415,000
|
|
|
$
|
9.25
|
|
Forfeited
|
|
(98,751
|
)
|
|
$
|
8.17
|
|
|
—
|
|
|
$
|
—
|
|
Vested
|
|
(153,745
|
)
|
|
$
|
9.13
|
|
|
—
|
|
|
$
|
—
|
|
Non-vested at end of period
|
|
580,004
|
|
|
$
|
8.02
|
|
|
415,000
|
|
|
$
|
9.25
|
|
|
Three Months Ended September 30, 2016
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
2,273,323
|
|
|
$
|
7.89
|
|
|
$
|
539,367
|
|
Exercised
|
(336,360
|
)
|
|
$
|
4.86
|
|
|
$
|
854,271
|
|
Forfeited
|
(66,563
|
)
|
|
$
|
8.12
|
|
|
—
|
|
|
Options outstanding at end of period
|
1,870,400
|
|
|
$
|
8.43
|
|
|
$
|
1,059,282
|
|
|
Three Months Ended September 30, 2015
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
3,327,207
|
|
|
$
|
6.59
|
|
|
$
|
8,791,060
|
|
Exercised
|
(389,507
|
)
|
|
$
|
1.94
|
|
|
$
|
2,497,074
|
|
Forfeited
|
(12,813
|
)
|
|
$
|
7.16
|
|
|
—
|
|
|
Options outstanding at end of period
|
2,924,887
|
|
|
$
|
7.20
|
|
|
$
|
3,175,484
|
|
|
Nine Months Ended September 30, 2016
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
2,673,512
|
|
|
$
|
7.46
|
|
|
$
|
5,485,248
|
|
Exercised
|
(618,110
|
)
|
|
$
|
4.31
|
|
|
$
|
2,198,143
|
|
Forfeited
|
(185,002
|
)
|
|
$
|
8.16
|
|
|
—
|
|
|
Options outstanding at end of period
|
1,870,400
|
|
|
$
|
8.43
|
|
|
$
|
1,059,282
|
|
Exercisable at end of period
|
1,574,804
|
|
|
$
|
8.47
|
|
|
$
|
946,591
|
|
|
Nine Months Ended September 30, 2015
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
4,667,738
|
|
|
$
|
6.14
|
|
|
$
|
19,357,512
|
|
Exercised
|
(1,552,788
|
)
|
|
$
|
7.25
|
|
|
$
|
8,009,410
|
|
Forfeited
|
(190,063
|
)
|
|
$
|
10.78
|
|
|
—
|
|
|
Options outstanding at end of period
|
2,924,887
|
|
|
$
|
7.20
|
|
|
$
|
3,175,484
|
|
Exercisable at end of period
|
2,181,725
|
|
|
$
|
6.81
|
|
|
$
|
3,126,162
|
|
|
Options Outstanding
|
|
Options
Exercisable
|
|||||
Exercise Price
|
Number
Outstanding
|
|
Weighted-
Average
Remaining
Contractual
Life
|
|
Number
Exercisable
|
|||
|
|
|
(in years)
|
|
|
|||
$ 6.00 - $ 8.99
|
1,153,562
|
|
|
2.4
|
|
|
971,091
|
|
$ 9.00 - $ 14.50
|
716,838
|
|
|
3.3
|
|
|
603,713
|
|
|
1,870,400
|
|
|
|
|
1,574,804
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
By Segment:
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Tech & Clearance
|
$
|
33,971
|
|
|
$
|
35,723
|
|
|
$
|
102,130
|
|
|
$
|
104,688
|
|
Global Industry Group
|
15,352
|
|
|
18,865
|
|
|
48,452
|
|
|
59,080
|
|
||||
Healthcare
|
6,735
|
|
|
6,912
|
|
|
20,648
|
|
|
19,473
|
|
||||
Corporate & Other
|
15
|
|
|
3,638
|
|
|
802
|
|
|
11,469
|
|
||||
Total revenues
|
$
|
56,073
|
|
|
$
|
65,138
|
|
|
$
|
172,032
|
|
|
$
|
194,710
|
|
|
|
|
|
|
|
|
|
||||||||
Depreciation:
|
|
|
|
|
|
|
|
||||||||
Tech & Clearance
|
$
|
1,620
|
|
|
$
|
1,635
|
|
|
$
|
5,128
|
|
|
$
|
4,845
|
|
Global Industry Group
|
234
|
|
|
231
|
|
|
686
|
|
|
695
|
|
||||
Healthcare
|
539
|
|
|
464
|
|
|
1,630
|
|
|
1,025
|
|
||||
Corporate & Other
|
85
|
|
|
34
|
|
|
195
|
|
|
256
|
|
||||
Total depreciation
|
$
|
2,478
|
|
|
$
|
2,364
|
|
|
$
|
7,639
|
|
|
$
|
6,821
|
|
|
|
|
|
|
|
|
|
||||||||
Amortization:
|
|
|
|
|
|
|
|
||||||||
Tech & Clearance
|
$
|
233
|
|
|
$
|
863
|
|
|
$
|
1,690
|
|
|
$
|
2,631
|
|
Global Industry Group
|
1,074
|
|
|
2,063
|
|
|
3,619
|
|
|
6,901
|
|
||||
Healthcare
|
218
|
|
|
317
|
|
|
654
|
|
|
951
|
|
||||
Corporate & Other
|
45
|
|
|
133
|
|
|
143
|
|
|
392
|
|
||||
Total amortization
|
$
|
1,570
|
|
|
$
|
3,376
|
|
|
$
|
6,106
|
|
|
$
|
10,875
|
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss):
|
|
|
|
|
|
|
|
||||||||
Tech & Clearance
|
$
|
12,896
|
|
|
$
|
14,207
|
|
|
$
|
38,020
|
|
|
$
|
39,677
|
|
Global Industry Group
|
(22,817
|
)
|
|
1,583
|
|
|
(19,694
|
)
|
|
5,608
|
|
||||
Healthcare
|
(366
|
)
|
|
136
|
|
|
(537
|
)
|
|
213
|
|
||||
Corporate & Other
|
(5,796
|
)
|
|
(4,968
|
)
|
|
(22,745
|
)
|
|
(14,864
|
)
|
||||
Operating income (loss)
|
(16,083
|
)
|
|
10,958
|
|
|
(4,956
|
)
|
|
30,634
|
|
||||
Interest expense
|
(901
|
)
|
|
(831
|
)
|
|
(2,593
|
)
|
|
(2,472
|
)
|
||||
Other income (expense)
|
(1
|
)
|
|
7
|
|
|
(33
|
)
|
|
(2
|
)
|
||||
Income (loss) before income taxes
|
$
|
(16,985
|
)
|
|
$
|
10,134
|
|
|
$
|
(7,582
|
)
|
|
$
|
28,160
|
|
|
|
|
|
|
|
|
|
||||||||
Capital expenditures:
|
|
|
|
|
|
|
|
||||||||
Tech & Clearance
|
$
|
1,718
|
|
|
$
|
1,370
|
|
|
$
|
5,131
|
|
|
$
|
4,013
|
|
Global Industry Group
|
312
|
|
|
47
|
|
|
853
|
|
|
569
|
|
||||
Healthcare
|
245
|
|
|
532
|
|
|
642
|
|
|
2,160
|
|
||||
Corporate & Other
|
650
|
|
|
29
|
|
|
1,616
|
|
|
61
|
|
||||
Total capital expenditures
|
$
|
2,925
|
|
|
$
|
1,978
|
|
|
$
|
8,242
|
|
|
$
|
6,803
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
By Geography:
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
United States
|
$
|
41,617
|
|
|
$
|
46,682
|
|
|
$
|
126,617
|
|
|
$
|
139,225
|
|
United Kingdom
|
5,291
|
|
|
8,725
|
|
|
18,875
|
|
|
27,905
|
|
||||
EMEA, APAC and Canada (1)
|
9,165
|
|
|
9,731
|
|
|
26,540
|
|
|
27,580
|
|
||||
Non-United States
|
14,456
|
|
|
18,456
|
|
|
45,415
|
|
|
55,485
|
|
||||
Total revenues
|
$
|
56,073
|
|
|
$
|
65,138
|
|
|
$
|
172,032
|
|
|
$
|
194,710
|
|
|
|
|
|
|
|
|
|
||||||||
(1) Europe (excluding United Kingdom), the Middle East and Africa (“EMEA”) and Asia-Pacific (“APAC”)
|
|
September 30,
2016 |
|
December 31,
2015 |
||||
Total assets:
|
|
|
|
||||
Tech & Clearance
|
$
|
173,872
|
|
|
$
|
177,519
|
|
Global Industry Group
|
107,050
|
|
|
150,111
|
|
||
Healthcare
|
15,287
|
|
|
18,134
|
|
||
Corporate & Other
|
17,576
|
|
|
23,171
|
|
||
Total assets
|
$
|
313,785
|
|
|
$
|
368,935
|
|
|
Tech & Clearance
|
|
Global Industry Group
|
|
Healthcare
|
|
Corporate & Other
|
|
Total
|
||||||||||
Goodwill at December 31, 2015
|
$
|
95,523
|
|
|
$
|
80,096
|
|
|
$
|
6,269
|
|
|
$
|
16,710
|
|
|
$
|
198,598
|
|
Foreign currency translation adjustment
|
(1,111
|
)
|
|
(5,388
|
)
|
|
—
|
|
|
(2,090
|
)
|
|
(8,589
|
)
|
|||||
Impairment
|
—
|
|
|
(15,369
|
)
|
|
—
|
|
|
—
|
|
|
(15,369
|
)
|
|||||
Goodwill at September 30, 2016
|
$
|
94,412
|
|
|
$
|
59,339
|
|
|
$
|
6,269
|
|
|
$
|
14,620
|
|
|
$
|
174,640
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Income (loss) from continuing operations—basic and diluted
|
$
|
(16,841
|
)
|
|
$
|
6,511
|
|
|
$
|
(10,876
|
)
|
|
$
|
17,281
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding—basic
|
47,719
|
|
|
51,228
|
|
|
48,596
|
|
|
51,792
|
|
||||
Add shares issuable from stock-based awards
|
—
|
|
|
1,002
|
|
|
—
|
|
|
1,264
|
|
||||
Weighted-average shares outstanding—diluted
|
47,719
|
|
|
52,230
|
|
|
48,596
|
|
|
53,056
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Basic earnings (loss) per share
|
$
|
(0.35
|
)
|
|
$
|
0.13
|
|
|
$
|
(0.22
|
)
|
|
$
|
0.33
|
|
Diluted earnings (loss) per share
|
$
|
(0.35
|
)
|
|
$
|
0.12
|
|
|
$
|
(0.22
|
)
|
|
$
|
0.33
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
•
|
Tech & Clearance— Dice, Dice Europe and ClearanceJobs
|
•
|
Global Industry Group— eFinancialCareers, Rigzone, Hcareers and BioSpace
|
•
|
Healthcare— Health eCareers
|
|
Three Months Ended September 30,
|
|
Increase (Decrease)
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Tech & Clearance
|
$
|
33,971
|
|
|
$
|
35,723
|
|
|
$
|
(1,752
|
)
|
|
(4.9
|
)%
|
eFinancialCareers
|
8,766
|
|
|
9,287
|
|
|
(521
|
)
|
|
(5.6
|
)%
|
|||
Rigzone
|
2,122
|
|
|
4,734
|
|
|
(2,612
|
)
|
|
(55.2
|
)%
|
|||
Hcareers
|
3,631
|
|
|
3,900
|
|
|
(269
|
)
|
|
(6.9
|
)%
|
|||
BioSpace
|
833
|
|
|
944
|
|
|
(111
|
)
|
|
(11.8
|
)%
|
|||
Global Industry Group
|
15,352
|
|
|
18,865
|
|
|
(3,513
|
)
|
|
(18.6
|
)%
|
|||
Healthcare
|
6,735
|
|
|
6,912
|
|
|
(177
|
)
|
|
(2.6
|
)%
|
|||
Corporate & Other
|
15
|
|
|
3,638
|
|
|
(3,623
|
)
|
|
(99.6
|
)%
|
|||
Total revenues
|
$
|
56,073
|
|
|
$
|
65,138
|
|
|
$
|
(9,065
|
)
|
|
(13.9
|
)%
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Cost of revenues
|
$
|
7,943
|
|
|
$
|
9,765
|
|
|
$
|
(1,822
|
)
|
|
(18.7
|
)%
|
Percentage of revenues
|
14.2
|
%
|
|
15.0
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Product development
|
$
|
6,018
|
|
|
$
|
7,938
|
|
|
$
|
(1,920
|
)
|
|
(24.2
|
)%
|
Percentage of revenues
|
10.7
|
%
|
|
12.2
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Sales and marketing
|
$
|
19,425
|
|
|
$
|
19,779
|
|
|
$
|
(354
|
)
|
|
(1.8
|
)%
|
Percentage of revenues
|
34.6
|
%
|
|
30.4
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
General and administrative
|
$
|
10,101
|
|
|
$
|
10,958
|
|
|
$
|
(857
|
)
|
|
(7.8
|
)%
|
Percentage of revenues
|
18.0
|
%
|
|
16.8
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
(in thousands, except percentages)
|
||||||||||||||
Depreciation
|
$
|
2,478
|
|
|
$
|
2,364
|
|
|
$
|
114
|
|
|
4.8
|
%
|
Percentage of revenues
|
4.4
|
%
|
|
3.6
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Amortization
|
$
|
1,570
|
|
|
$
|
3,376
|
|
|
$
|
(1,806
|
)
|
|
(53.5
|
)%
|
Percentage of revenues
|
2.8
|
%
|
|
5.2
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Interest expense
|
$
|
901
|
|
|
$
|
831
|
|
|
$
|
70
|
|
|
8.4
|
%
|
Percentage of revenues
|
1.6
|
%
|
|
1.3
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
||||||
2016
|
|
2015
|
|||||
(in thousands, except
percentages)
|
|||||||
Income (loss) before income taxes
|
$
|
(16,985
|
)
|
|
$
|
10,134
|
|
Income tax (benefit) expense
|
(144
|
)
|
|
3,623
|
|
||
Effective tax rate
|
0.8
|
%
|
|
35.8
|
%
|
|
Nine Months Ended September 30,
|
|
Increase (Decrease)
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Tech & Clearance
|
$
|
102,130
|
|
|
$
|
104,688
|
|
|
$
|
(2,558
|
)
|
|
(2.4
|
)%
|
eFinancialCareers
|
26,724
|
|
|
26,800
|
|
|
(76
|
)
|
|
(0.3
|
)%
|
|||
Rigzone
|
7,455
|
|
|
16,795
|
|
|
(9,340
|
)
|
|
(55.6
|
)%
|
|||
Hcareers
|
11,477
|
|
|
12,217
|
|
|
(740
|
)
|
|
(6.1
|
)%
|
|||
BioSpace
|
2,796
|
|
|
3,268
|
|
|
(472
|
)
|
|
(14.4
|
)%
|
|||
Global Industry Group
|
48,452
|
|
|
59,080
|
|
|
(10,628
|
)
|
|
(18.0
|
)%
|
|||
Healthcare
|
20,648
|
|
|
19,473
|
|
|
1,175
|
|
|
6.0
|
%
|
|||
Corporate & Other
|
802
|
|
|
11,469
|
|
|
(10,667
|
)
|
|
(93.0
|
)%
|
|||
Total revenues
|
$
|
172,032
|
|
|
$
|
194,710
|
|
|
$
|
(22,678
|
)
|
|
(11.6
|
)%
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Cost of revenues
|
$
|
24,557
|
|
|
$
|
29,255
|
|
|
$
|
(4,698
|
)
|
|
(16.1
|
)%
|
Percentage of revenues
|
14.3
|
%
|
|
15.0
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Product development
|
$
|
19,323
|
|
|
$
|
22,082
|
|
|
$
|
(2,759
|
)
|
|
(12.5
|
)%
|
Percentage of revenues
|
11.2
|
%
|
|
11.3
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Sales and marketing
|
$
|
58,573
|
|
|
$
|
60,984
|
|
|
$
|
(2,411
|
)
|
|
(4.0
|
)%
|
Percentage of revenues
|
34.0
|
%
|
|
31.3
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
General and administrative
|
$
|
32,822
|
|
|
$
|
34,059
|
|
|
$
|
(1,237
|
)
|
|
(3.6
|
)%
|
Percentage of revenues
|
19.1
|
%
|
|
17.5
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
||||||||
2016
|
|
2015
|
|
||||||||||
(in thousands, except percentages)
|
|||||||||||||
Disposition related and other costs
|
$
|
3,347
|
|
|
$
|
—
|
|
|
$
|
3,347
|
|
|
n.m.
|
Percentage of revenues
|
1.9
|
%
|
|
—
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
(in thousands, except percentages)
|
||||||||||||||
Depreciation
|
$
|
7,639
|
|
|
$
|
6,821
|
|
|
$
|
818
|
|
|
12.0
|
%
|
Percentage of revenues
|
4.4
|
%
|
|
3.5
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Amortization
|
$
|
6,106
|
|
|
$
|
10,875
|
|
|
$
|
(4,769
|
)
|
|
(43.9
|
)%
|
Percentage of revenues
|
3.5
|
%
|
|
5.6
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2016
|
|
2015
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Interest expense
|
$
|
2,593
|
|
|
$
|
2,472
|
|
|
$
|
121
|
|
|
4.9
|
%
|
Percentage of revenues
|
1.5
|
%
|
|
1.3
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
||||||
2016
|
|
2015
|
|||||
(in thousands, except
percentages)
|
|||||||
Income (loss) before income taxes
|
$
|
(7,582
|
)
|
|
$
|
28,160
|
|
Income tax expense
|
3,294
|
|
|
10,879
|
|
||
Effective tax rate
|
(43.4
|
)%
|
|
38.6
|
%
|
•
|
Adjusted EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;
|
•
|
Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
|
•
|
Adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on your debt;
|
•
|
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements; and
|
•
|
Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.
|
|
For the nine months ended September 30,
|
||||||
2016
|
|
2015
|
|||||
Reconciliation of Net Income (Loss) to Adjusted EBITDA:
|
|
|
|
||||
Net income (loss)
|
$
|
(10,876
|
)
|
|
$
|
17,281
|
|
Interest expense
|
2,593
|
|
|
2,472
|
|
||
Income tax expense
|
3,294
|
|
|
10,879
|
|
||
Depreciation
|
7,639
|
|
|
6,821
|
|
||
Amortization of intangible assets
|
6,106
|
|
|
10,875
|
|
||
Impairment of goodwill
|
15,369
|
|
|
—
|
|
||
Impairment of intangible assets
|
9,252
|
|
|
—
|
|
||
Non-cash stock compensation expense
|
7,850
|
|
|
7,490
|
|
||
Severance
—
Slashdot Media
|
981
|
|
|
—
|
|
||
Accelerated stock based compensation expense
—
Slashdot Media
|
900
|
|
|
—
|
|
||
Loss on sale of business
|
639
|
|
|
—
|
|
||
Other
|
33
|
|
|
2
|
|
||
Adjusted EBITDA
|
$
|
43,780
|
|
|
$
|
55,820
|
|
|
|
|
|
||||
Reconciliation of Operating Cash Flows to Adjusted EBITDA:
|
|
|
|
||||
Net cash provided by operating activities
|
$
|
36,612
|
|
|
$
|
49,369
|
|
Interest expense
|
2,593
|
|
|
2,472
|
|
||
Amortization of deferred financing costs
|
(243
|
)
|
|
(313
|
)
|
||
Income tax expense
|
3,294
|
|
|
10,879
|
|
||
Deferred income taxes
|
1,977
|
|
|
373
|
|
||
Severance—Slashdot Media
|
981
|
|
|
—
|
|
||
Change in accrual for unrecognized tax benefits
|
(166
|
)
|
|
(172
|
)
|
||
Change in accounts receivable
|
(8,047
|
)
|
|
(3,437
|
)
|
||
Change in deferred revenue
|
493
|
|
|
2,132
|
|
||
Changes in working capital and other
|
6,286
|
|
|
(5,483
|
)
|
||
Adjusted EBITDA
|
$
|
43,780
|
|
|
$
|
55,820
|
|
|
For the nine months ended September 30,
|
||||||
2016
|
|
2015
|
|||||
Cash from operating activities
|
$
|
36,612
|
|
|
$
|
49,369
|
|
Purchases of fixed assets
|
(8,461
|
)
|
|
(6,710
|
)
|
||
Free cash flow
|
$
|
28,151
|
|
|
$
|
42,659
|
|
|
For the nine months ended September 30,
|
||||||
2016
|
|
2015
|
|||||
Cash from operating activities
|
$
|
36,612
|
|
|
$
|
49,369
|
|
Cash from investing activities
|
(6,032
|
)
|
|
(6,710
|
)
|
||
Cash from financing activities
|
(34,894
|
)
|
|
(35,919
|
)
|
|
Payments due by period
|
||||||||||||||||||
Total
|
|
Less Than 1 Year
|
|
2-3 Years
|
|
4-5 Years
|
|
More Than 5 Years
|
|||||||||||
|
(in thousands)
|
||||||||||||||||||
Credit Agreement
|
$
|
92,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
92,000
|
|
|
$
|
—
|
|
Operating lease obligations
|
23,895
|
|
|
1,169
|
|
|
8,495
|
|
|
7,000
|
|
|
7,231
|
|
|||||
Total contractual obligations
|
$
|
115,895
|
|
|
$
|
1,169
|
|
|
$
|
8,495
|
|
|
$
|
99,000
|
|
|
$
|
7,231
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
|
|
V
|
VI
|
Approval Date
|
December 2014
|
December 2015
|
Authorized Repurchase Amount of Common Stock
|
$50 million
|
$50 million
|
Effective Dates
|
December 2014 to December 2015
|
December 2015 to December 2016
|
Period
|
|
(a) Total Number of Shares Purchased [1]
|
|
(b) Average Price Paid per Share
|
|
(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
(d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
|
|||||||||||||
July 1 through July 31, 2016
|
|
410,000
|
|
|
|
$
|
6.70
|
|
|
|
410,000
|
|
|
|
$
|
22,313,000
|
|
|
|||
August 1 through August 31, 2016
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
22,313,000
|
|
|
|||||
September 1 through September 30, 2016
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
22,313,000
|
|
|
|||||
Total
|
|
410,000
|
|
|
|
$
|
6.70
|
|
|
|
410,000
|
|
|
|
|
|
10.1
|
|
Separation Agreement and General Release of All Claims, dated as of August 1, 2016, among DHI Group, Inc., Dice Inc. and John Roberts (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-33584) filed on August 1, 2016).
|
31.1*
|
|
Certifications of Michael Durney, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2*
|
|
Certifications of Michael Durney, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1*
|
|
Certifications of Michael Durney, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2*
|
|
Certifications of Michael Durney, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101.INS
|
|
XBRL Instance Document.
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
Filed herewith.
|
|
|
|
DHI GROUP, INC.
|
|
Date:
|
November 1, 2016
|
|
Registrant
|
|
|
|
|
|
|
|
|
|
|
/s/ Michael P. Durney
|
|
|
|
|
Michael P. Durney
President and Chief Executive Officer |
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
/s/ Michael P. Durney
|
|
|
|
|
Michael P. Durney
Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer)
|
10.1
|
|
Separation Agreement and General Release of All Claims, dated as of August 1, 2016, among DHI Group, Inc., Dice Inc. and John Roberts (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-33584) filed on August 1, 2016).
|
31.1*
|
|
Certifications of Michael Durney, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2*
|
|
Certifications of Michael Durney, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1*
|
|
Certifications of Michael Durney, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2*
|
|
Certifications of Michael Durney, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101.INS
|
|
XBRL Instance Document.
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
|
Filed herewith
|
1 Year DHI Chart |
1 Month DHI Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions